EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma

Diego Velasco-Rodríguez, Inés Martínez-Alfonzo, Alberto Eterio Velasco-Valdazo, Nuria Revilla, Ignacio Mahíllo-Fernández, Elham Askari, Nerea Castro-Quismondo, Rosa Vidal Laso, Amalia Domingo-González, Juana Serrano-López, Elena Prieto, Belén Rosado und 10 weitere

Journal of Thrombosis and Thrombolysis · 2023

DOI: 10.1007/s11239-022-02765-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2023. Verfasst von Diego Velasco-Rodríguez und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain. diegovelascorodriguez@gmail.com. Hauptthemen laut MEDLINE: Multiple Myeloma, Venous Thromboembolism, Thrombophilia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The issue of how to identify newly diagnosed multiple myeloma (NDMM) patients requiring thromboprophylaxis remains unsolved. Several changes in thrombin generation (TG)-derived parameters have been described in multiple myeloma (MM) patients recently. Assessment of prothrombotic risk with a fully automated TG analyzer could reduce interlaboratory variability. Our objective was to determine whether ST-Genesia® could reveal a hypercoagulable state in NDMM compared to healthy controls. We conducted a multicenter observational study of NDMM requiring initial treatment to compare TG parameters obtained with ST-Genesia® analyzer and ST-ThromboScreen® reagent with a control group. Clinical data were obtained from medical records and blood samples were collected before initial anti-myeloma therapy. A thrombophilia panel was performed in all patients. Compared to age- and sex-matched controls (n = 83), NDMM patients (n = 83) had significantly higher peak height, higher velocity index, shorter time-to-peak and lower percentage of endogenous thrombin potential (ETP) inhibition after adding thrombomodulin (TM) (ETP%inh). NDMM on prophylactic low molecular weight heparin (LMWH) showed reduced both peak height and velocity index compared to NDMM who had not yet started VTE prophylaxis, similar to that of controls. Moreover, partial correction of ETP%inh was observed in MM patients on LMWH. The presence of a thrombophilia did not modify the TG phenotype. Untreated NDMM patients showed an enhanced TG, regardless of their thrombophilia status. They generate a higher peak of thrombin, take less time to produce it, and exhibit resistance to TM inhibition. Our findings suggest that standard prophylactic dose of LMWH may reduce TG at levels of healthy controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaVenous ThromboembolismThrombophiliaHumansThrombinAnticoagulantsHeparin, Low-Molecular-WeightBlood Coagulation Tests

Stichwörter der Autor:innen

HypercoagulabilityMultiple myelomaThrombin generationThrombophiliaThrombotic risk

Substanzen

ThrombinAnticoagulantsHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain. diegovelascorodriguez@gmail.com.
  • Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, Avenida Reyes Católicos 2, 28040, Madrid, Spain. diegovelascorodriguez@gmail.com.
  • Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain.
  • Department of Hematology, Hospital Universitario Rey Juan Carlos. Móstoles, Madrid, Spain.
  • Department of Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Department of Epidemiology, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain.

Zitieren

APA

Velasco-Rodríguez, D., Martínez-Alfonzo, I., Velasco-Valdazo, A. E., Revilla, N., Mahíllo-Fernández, I., Askari, E., Castro-Quismondo, N., Laso, R. V., Domingo-González, A., Serrano-López, J., Prieto, E., Rosado, B., Blanchard, M. J., Martín-Herrero, S., García-Raso, A., Bueno, M. Á., de la Plaza, R., Peñaherrera, M., López, I. G., …, & Llamas-Sillero, P. (2023). Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-022-02765-8

Vancouver

Velasco-Rodríguez D, Martínez-Alfonzo I, Velasco-Valdazo AE, Revilla N, Mahíllo-Fernández I, Askari E, et al. Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma. Journal of Thrombosis and Thrombolysis. 2023. doi:10.1007/s11239-022-02765-8

BibTeX
@article{VelascoRodrguez2023,
  author = {Velasco-Rodríguez, Diego and Martínez-Alfonzo, Inés and Velasco-Valdazo, Alberto Eterio and Revilla, Nuria and Mahíllo-Fernández, Ignacio and Askari, Elham and Castro-Quismondo, Nerea and Laso, Rosa Vidal and Domingo-González, Amalia and Serrano-López, Juana and Prieto, Elena and Rosado, Belén and Blanchard, María Jesús and Martín-Herrero, Sara and García-Raso, Aránzazu and Bueno, María Ángeles and de la Plaza, Reyes and Peñaherrera, Meybi and López, Irene Gómez and López-Jiménez, Javier and Martínez-López, Joaquín and Llamas-Sillero, Pilar},
  title = {Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2023},
  doi = {10.1007/s11239-022-02765-8}
}
Kostenlos starten →